Background-Patients with advanced diabetic eye disease are commonly in poor general health. In addition to the ocular status, life expectancy is an important factor in the decision whether and how to perform vitreous surgery. The present study investigates mortality and risk factors for survival in diabetic patients following vitrectomy. Methods-The follow up of 332 consecutive patients who underwent vitrectomy for complications of diabetic retinopathy between 1990 and 1994 was studied retrospectively. Survival and risk factors for survival were analysed using the KaplanMeier life table method and for multivariate analysis the Cox proportional hazard model. Results-The 5 year survival rate was 68%. Absence of heart disease was the most important predicting factor for survival. Fifty per cent of the patients with heart disease had died within 3.5 years. Patients without heart disease had a 5 year survival rate of 90%. Other significant, independent risk factors were age and presence of nephropathy. Conclusion-In diabetic patients undergoing vitrectomy the presence of heart disease indicates a poor prognosis for survival. This should be taken into consideration for indications and strategies in cases of vitrectomy. (Br_J Ophthalmol 1996;80:640- Systemic factors recorded were age, sex, duration of diabetes, insulin treatment, age at diagnosis of diabetes, presence of heart disease (history of myocardial infarction, symptoms of heart failure upon clinical examination or chest x ray, signs of congestion, signs of coronary heart disease on ECG), presence of arterial hypertension (antihypertensive medication or arterial blood pressure > 160/95 mm Hg), serum creatinine, history of renal dialysis, history of toe or foot amputation, body mass index as a measure for overweight (body weight (kg) divided by height (m')). Ocular factors recorded were presence of cataract, visual acuity at last follow up, presence of retinal detachment, and rubeosis of the iris at the time of surgery.
Vitrectomy has become a standard treatment for complications of proliferative diabetic retinopathy. Many studies have investigated ocular factors which influence visual prognosis. Several indications for vitreous surgery have been defined.' However, in a situation where a surgeon is considering a vitrectomy for an individual diabetic patient, other extraocular factors cannot be ignored. Patients with severe proliferative diabetic retinopathy suffer from a systemic disease, not only affecting the eye, but also kidney, heart, nerves, and other organs. Improvement of anaesthesia techniques allows us to operate safely even these patients in poor health. When proposing to operate on a diabetic eye, the estimation of the life expectancy of the patient is an essential factor for the decision whether and how to operate. Considering the importance to the clinician, there are only few analyses of this factor.2" The purpose of the present study was to provide data for life expectancy and risk factors for survival in diabetic patients undergoing vitrectomy.
Patients and methods
We have reviewed the records of 337 consecutive patients (420 operated eyes) undergoing vitreous surgery for complications of diabetic retinopathy between 1990 and 1994 operated by the authors. For patients who were operated on both eyes only the data at the time of the first vitrectomy were considered. Data on ocular and systemic factors at the time of surgery were recorded in a computer data base. Preoperatively, chest x ray, ECG, and blood tests including serum creatinine were performed in all patients. All operations were performed under general anaesthesia with the patient in a stable situation of general health. No serious complications or other serious systemic complications occurred during surgery or in the immediate postoperative period.
Systemic factors recorded were age, sex, duration of diabetes, insulin treatment, age at diagnosis of diabetes, presence of heart disease (history of myocardial infarction, symptoms of heart failure upon clinical examination or chest x ray, signs of congestion, signs of coronary heart disease on ECG), presence of arterial hypertension (antihypertensive medication or arterial blood pressure > 160/95 mm Hg), serum creatinine, history of renal dialysis, history of toe or foot amputation, body mass index as a measure for overweight (body weight (kg) divided by height (m')). Ocular factors recorded were presence of cataract, visual acuity at last follow up, presence of retinal detachment, and rubeosis of the iris at the time of surgery.
Follow up data were obtained between January 1995 and October 1995. If the charts did not provide sufficient follow up, the information was obtained from the referring ophthalmologist, from the patient or his relatives by telephone inquiry, or from the residents' registration office. The mean follow up time was 26 (SD 15) months. Data were analysed using the Kaplan-Meier life table method. For univariate analysis of risk factors cumulative survival was compared using the log rank test. For multivariate analysis of risk factors the Cox proportional hazard model was used.
Results
Five patients had moved abroad and could not be traced. These cases were excluded from the analysis. A total of 332 patients were further Time (months) Figure 1 Kaplan-Meier analysis ofsurvival of 332 patients after vitrectomy for diabetic retinopathy.
analysed: 47 patients had died. Cumulative survival is shown in Figure 1 . The Table 1 . The results indicate that age, heart disease and renal failure were statistically independent factors for survival and heart disease was the most important risk factor for survival.
If the subgroup of patients with a diagnosis of diabetes before age 30 (mainly type I diabetics) was tested separately for risk factors for survival, the only significant predictor was the presence of heart disease. Creatinine and age were not significant factors in type I diabetics. Diabetic patients undergoing vitrectomy suffer from advanced proliferative diabetic retinopathy. The 5 year postoperative survival rate in the present study was 68%, similar to the published epidemiological data for mortality of patients with proliferative diabetic retinopathy.7 Other studies analysing survival following vitreous surgery in diabetic patients found 5 year survival rates of 73%,8 75%,2 80%,' and 85%,4 but the mean age in our study was about 10 years higher than in most of the other studies. A 10 year survival rate after vitreous surgery of 50% has been reported. 9 In large epidemiological studies of patients with diabetic retinopathy the main risk factors for survival, besides age, were renal failure and cardiovascular disease.7 Microalbuminuria has been shown to be related to cardiovascular mortality.'0 Diabetics with coronary heart disease have a particularly poor prognosis." Studies on the survival of diabetic patients following vitrectomy have identified age, duration of diabetes, age at diagnosis of diabetes, and the presence of nephropathy' as well as neuropathy4 as risk factors for survival. These studies have not included heart disease in their analyses. Cardiovascular disease is the most common cause of death in diabetic patients with about 75 % ultimately dying of coronary heart disease.'2 In our series the presence of heart disease was the main factor predicting survival. Fifty per cent of the patients with heart disease had died within 3.5 years while 90% of the patients without heart disease survived for more than 5 years. We also confirmed nephropathy as an independent risk factor for survival, but it was less important than heart disease. 
